Hereditary Amyloidosis Canada (HAC) and Regroupement québécois des maladies orphelines (RQMO) are pleased to announce a Call for Proposals for Unfolding Transthyretin Amyloidosis: The Akcea Canada Young Investigator Grants Program.
This new research program will provide trainees and early career investigators affiliated with Canadian academic centres and hospitals with funding for research into biomedical, clinical, health services or population health projects related to transthyretin amyloidosis. The application deadline is Friday, May 29, 2020. All applications will be assessed through a rigorous, competitive and independent peer-review process. It is anticipated that 2 to 4 grants will be awarded per year for the next 3 years. This program has been made possible thanks to Akcea Therapeutics Canada’s generous three-year financial commitment.